Sobi Presents Comprehensive Study Data on Extended Half-life Haemophilia Treatments at EAHAD
- Thursday, February 7, 2019, 3:21
- Environment
- Add a comment
STOCKHOLM, Feb. 7, 2019 /PRNewswire/ — Sobi™ will present data at the European Association of Haemophilia and Allied Disorders (EAHAD) conference in Prague, Czech Republic, 6-8 February 2019, showing evidence on the safety, efficacy and long-term benefits of its extended half-life…
Source: https://www.prnewswire.com:443/news-releases/sobi-presents-comprehensive-study-data-on-extended-half-life-haemophilia-treatments-at-eahad-300791540.html
About the Author
adminasapcorp has written 41274 stories on this site.